EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Ai Da Lotion improves eczema lesions via modulation of the JAK1/STAT3 pathway and regulation of apoptosis and oxidative stress

Yuan Li, Yangyang Liu, Zixiao Jiang, Haolin Wu, Jing Lin

Eurasian Journal of Medicine and Oncology · 2026-07-08 · 10 (5) · 026090094

DOI: 10.36922/ejmo026090094 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Ai Da Lotion is widely used for eczema in the clinic; however, its active ingredients and molecular mechanism remain unclear. Objective: We set out to define the molecular basis for how Ai Da Lotion—a compound traditional Chinese medicine preparation—acts to treat eczema, with the goal of generating sound scientific support for its clinical use and modern translational development. Methods: In this study, we combined ultra high-performance liquid chromatography–quadrupole time-of-flight mass spectrometry profiling with network pharmacology and molecular docking to identify the formula’s bioactive constituents and key targets, then validated these findings in keratinocyte-based models of eczema. Results: Chemical profiling identified 889 constituents, and physicochemical screening narrowed these to 42 candidate active compounds. Target network analysis uncovered 37 core nodes, with Janus kinase 1 (JAK1) and signal transducer and activator of transcription 3 (STAT3) emerging as the dominant regulatory pair. Two lead compounds—8-deoxylactucin and 6β-hydroxymethandrostenolone—bound JAK1 and STAT3 with high affinity (binding energy

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →